VET
Vermilion Energy Inc.
Oil & Gas Exploration & Production
Market Cap$1.71B
5Y Perf.+150.0%
Build Your Comparison
Side-by-side financial analysisVET
XOM
JPM
Try popular comparisons:
Stock Comparison
VET vs XOM vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
XOM
Exxon Mobil Corporation
Oil & Gas Integrated
Market Cap$623.01B
5Y Perf.+228.7%
JPM
JPMorgan Chase & Co.
Banks - Diversified
Market Cap$896.00B
5Y Perf.+241.0%
VET vs XOM vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot |  VET |  XOM |  JPM |
|---|---|---|---|
| Industry | Oil & Gas Exploration & Production | Oil & Gas Integrated | Banks - Diversified |
| Market Cap | $1.71B | $623.01B | $896.00B |
| Revenue (TTM) | $1.81B | $323.90B | $280.33B |
| Net Income (TTM) | $-814M | $28.84B | $57.05B |
| Gross Margin | 35.9% | 21.7% | 60.0% |
| Operating Margin | 20.2% | 10.5% | 25.9% |
| Forward P/E | 11.2x | 13.4x | 14.4x |
| Total Debt | $1.30B | $43.54B | $942.38B |
| Cash & Equiv. | $19M | $10.68B | $343.34B |
VET vs XOM vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
VET
XOM
JPM
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Vermilion Energy In… (VET) | 100 | 250.0 | +150.0% |
| Exxon Mobil Corpora… (XOM) | 100 | 328.7 | +228.7% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VET vs XOM vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: VET leads in 3 of 7 categories, making it the strongest pick for valuation and capital efficiency and dividend income and shareholder returns. Exxon Mobil Corporation is the stronger pick specifically for capital preservation and lower volatility and operational efficiency and capital deployment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇VET emerged as the overall leader. Track its performance:
VET
Vermilion Energy Inc.
The Defensive Pick
VET has the current edge in this matchup, primarily because of its strength in defensive.
- Beta -0.18, yield 4.1%, current ratio 0.84x
- Lower P/E (11.2x vs 14.4x)
- 4.1% yield, 3-year raise streak, vs XOM's 2.7%
Best for: defensive
XOM
Exxon Mobil Corporation
The Income Pick
XOM is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 43 yrs, beta -0.37, yield 2.7%
- Lower volatility, beta -0.37, Low D/E 16.3%, current ratio 1.15x
- Lower D/E ratio (16.3% vs 260.0%)
Best for: income & stability and sleep-well-at-night
JPM
JPMorgan Chase & Co.
The Banking Pick
JPM is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 3.3%, EPS growth 1.5%
- 465.8% 10Y total return vs XOM's 101.3%
- 3.3% NII/revenue growth vs VET's -15.0%
Best for: growth exposure and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth |  JPM | 3.3% NII/revenue growth vs VET's -15.0% |
| Value |  VET | Lower P/E (11.2x vs 14.4x) |
| Quality / Margins | JPM | 20.4% margin vs VET's -44.9% |
| Stability / Safety |  XOM | Lower D/E ratio (16.3% vs 260.0%) |
| Dividends | VET | 4.1% yield, 3-year raise streak, vs XOM's 2.7% |
| Momentum (1Y) | VET | +45.6% vs JPM's +21.8% |
| Efficiency (ROA) | XOM | 6.4% ROA vs VET's -13.8%, ROIC 8.6% vs 3.5% |
VET vs XOM vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2025
FY 2025
VET vs XOM vs JPM — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLJPMLAGGINGXOM
XOMExxon Mobil Corporati…
1leads
VETVermilion Energy Inc.
1leads
JPMJPMorgan Chase & Co.
2leads
6 Total Categories
CATEGORYLEADERvs VETvs XOMMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
JPM5/6
Valuation MetricsMultiples, price ratios, and targets
VET6/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
XOM5/9
Total Returns1Y, 3Y, 5Y total returns with dividends
JPM3/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM is the larger business by revenue, generating $323.9B annually — 178.6x VET's $1.8B. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to VET's -44.9%. On growth, XOM holds the edge at -1.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | VETVermilion Energy … | XOMExxon Mobil Corpo… | JPMJPMorgan Chase & … |
|---|---|---|---|
| RevenueTrailing 12 months | $1.8B | $323.9B | $280.3B |
| EBITDAEarnings before interest/tax | $1.2B | $59.9B | $81.4B |
| Net IncomeAfter-tax profit | -$814M | $28.8B | $57.0B |
| Free Cash FlowCash after capex | $301M | $23.6B | $100.9B |
| Gross MarginGross profit ÷ Revenue | +35.9% | +21.7% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +20.2% | +10.5% | +25.9% |
| Net MarginNet income ÷ Revenue | -44.9% | +8.9% | +20.4% |
| FCF MarginFCF ÷ Revenue | +16.6% | +7.3% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -16.4% | -1.3% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -10.9% | -11.0% | +16.0% |
JPM leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
VET leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 16.0x trailing earnings, JPM trades at a 27% valuation discount to XOM's 21.9x P/E. On an enterprise value basis, VET's 3.9x EV/EBITDA is more attractive than JPM's 18.4x.
| Metric | VETVermilion Energy … | XOMExxon Mobil Corpo… | JPMJPMorgan Chase & … |
|---|---|---|---|
| Market CapShares × price | $1.7B | $623.0B | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $2.6B | $655.9B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | -3.68x | 21.94x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.20x | 13.41x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.90x |
| EV / EBITDAEnterprise value multiple | 3.92x | 10.94x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 1.35x | 1.92x | 3.20x |
| Price / BookPrice ÷ Book value/share | 1.08x | 2.37x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 7.32x | 26.39x | 8.88x |
VET leads this category, winning 6 of 6 comparable metrics.
Profitability & Efficiency
XOM leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-34 for VET. XOM carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), JPM scores 5/9 vs XOM's 3/9, reflecting solid financial health.
| Metric | VETVermilion Energy … | XOMExxon Mobil Corpo… | JPMJPMorgan Chase & … |
|---|---|---|---|
| ROE (TTM)Return on equity | -33.7% | +10.7% | +15.9% |
| ROA (TTM)Return on assets | -13.8% | +6.4% | +1.3% |
| ROICReturn on invested capital | +3.5% | +8.6% | +4.5% |
| ROCEReturn on capital employed | +3.3% | +8.9% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 | 5 |
| Debt / EquityFinancial leverage | 0.59x | 0.16x | 2.60x |
| Net DebtTotal debt minus cash | $1.3B | $32.9B | $599.0B |
| Cash & Equiv.Liquid assets | $19M | $10.7B | $343.3B |
| Total DebtShort + long-term debt | $1.3B | $43.5B | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 2.53x | 69.44x | 0.74x |
XOM leads this category, winning 5 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
JPM leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in XOM five years ago would be worth $26,725 today (with dividends reinvested), compared to $14,136 for VET. Over the past 12 months, VET leads with a +45.6% total return vs JPM's +21.8%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs VET's 1.3% — a key indicator of consistent wealth creation.
| Metric | VETVermilion Energy … | XOMExxon Mobil Corpo… | JPMJPMorgan Chase & … |
|---|---|---|---|
| YTD ReturnYear-to-date | +31.7% | +21.5% | -0.5% |
| 1-Year ReturnPast 12 months | +45.6% | +37.7% | +21.8% |
| 3-Year ReturnCumulative with dividends | +4.0% | +49.2% | +138.2% |
| 5-Year ReturnCumulative with dividends | +41.4% | +167.3% | +118.2% |
| 10-Year ReturnCumulative with dividends | -39.7% | +101.3% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +1.3% | +14.3% | +33.6% |
JPM leads this category, winning 3 of 6 comparable metrics.
Risk & Volatility
Evenly matched — XOM and JPM each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.37 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 95.1% from its 52-week high vs VET's 75.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | VETVermilion Energy … | XOMExxon Mobil Corpo… | JPMJPMorgan Chase & … |
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.18x | -0.37x | 0.94x |
| 52-Week HighHighest price in past year | $14.82 | $176.41 | $337.25 |
| 52-Week LowLowest price in past year | $7.00 | $105.53 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +75.2% | +83.3% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 40.9 | 42.4 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 13.9M | 7.0M |
Evenly matched — XOM and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Evenly matched — VET and XOM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: VET as "Hold", XOM as "Hold", JPM as "Buy". Consensus price targets imply 15.7% upside for XOM (target: $170) vs -3.7% for VET (target: $11). For income investors, VET offers the higher dividend yield at 4.10% vs JPM's 1.86%.
| Metric | VETVermilion Energy … | XOMExxon Mobil Corpo… | JPMJPMorgan Chase & … |
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $10.74 | $170.08 | $339.75 |
| # AnalystsCovering analysts | 10 | 55 | 61 |
| Dividend YieldAnnual dividend ÷ price | +4.1% | +2.7% | +1.9% |
| Dividend StreakConsecutive years of raises | 3 | 43 | 15 |
| Dividend / ShareAnnual DPS | $0.64 | $4.00 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.5% | +3.3% | +3.9% |
Evenly matched — VET and XOM each lead in 1 of 2 comparable metrics.
Key Takeaway
JPM leads in 2 of 6 categories (Income & Cash Flow, Total Returns). VET leads in 1 (Valuation Metrics). 2 tied.
Best OverallJPMorgan Chase & Co. (JPM)Leads 2 of 6 categories
Loading custom metrics...
VET vs XOM vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VET or XOM or JPM a better buy right now?
For growth investors, JPMorgan Chase & Co.
(JPM) is the stronger pick with 3. 3% revenue growth year-over-year, versus -15. 0% for Vermilion Energy Inc. (VET). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VET or XOM or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 0x versus Exxon Mobil Corporation at 21. 9x. On forward P/E, Vermilion Energy Inc. is actually cheaper at 11. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — VET or XOM or JPM?
Over the past 5 years, Exxon Mobil Corporation (XOM) delivered a total return of +167.
3%, compared to +41. 4% for Vermilion Energy Inc. (VET). Over 10 years, the gap is even starker: JPM returned +465. 8% versus VET's -39. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VET or XOM or JPM?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
37β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately -353% more volatile than XOM relative to the S&P 500. On balance sheet safety, Exxon Mobil Corporation (XOM) carries a lower debt/equity ratio of 16% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — VET or XOM or JPM?
By revenue growth (latest reported year), JPMorgan Chase & Co.
(JPM) is pulling ahead at 3. 3% versus -15. 0% for Vermilion Energy Inc. (VET). On earnings-per-share growth, the picture is similar: JPMorgan Chase & Co. grew EPS 1. 5% year-over-year, compared to -1313. 3% for Vermilion Energy Inc.. Over a 3-year CAGR, XOM leads at -6. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VET or XOM or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus -37. 0% for Vermilion Energy Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 9. 5% for VET. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VET or XOM or JPM more undervalued right now?
On forward earnings alone, Vermilion Energy Inc.
(VET) trades at 11. 2x forward P/E versus 14. 4x for JPMorgan Chase & Co. — 3. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for XOM: 15. 7% to $170. 08.
08Which pays a better dividend — VET or XOM or JPM?
All stocks in this comparison pay dividends.
Vermilion Energy Inc. (VET) offers the highest yield at 4. 1%, versus 1. 9% for JPMorgan Chase & Co. (JPM).
09Is VET or XOM or JPM better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
37), 2. 7% yield, +101. 3% 10Y return). Both have compounded well over 10 years (XOM: +101. 3%, JPM: +465. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VET and XOM and JPM?
These companies operate in different sectors (VET (Energy) and XOM (Energy) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: VET is a small-cap income-oriented stock; XOM is a large-cap quality compounder stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.